Replies to post #210868 on Biotech Values

[DewDiligence]

SVRA sells 9.68M* shares @$4.75—an 8% discount to yesterday’s close:

https://finance.yahoo.com/news/savara-announces-pricing-public-offering-131600050.html

SVRA is the result of a reverse merger involving MSTX (#msg-127699319, #msg-130803333).

*Assuming exercise of underwriter’s option.